4SC AG (4SC AG) Additional Paid-In Capital : $261.23 Mil(As of Dec. 2023)

View and export this data going back to 2008. Start your Free Trial

What is 4SC AG Additional Paid-In Capital?

4SC AG's quarterly additional paid-in capital increased from Dec. 2022 ($253.76 Mil) to Jun. 2023 ($259.53 Mil) and increased from Jun. 2023 ($259.53 Mil) to Dec. 2023 ($261.23 Mil).

4SC AG's annual additional paid-in capital declined from Dec. 2021 ($270.67 Mil) to Dec. 2022 ($253.76 Mil) but then increased from Dec. 2022 ($253.76 Mil) to Dec. 2023 ($261.23 Mil).

4SC AG Additional Paid-In Capital Historical Data

The historical data trend for 4SC AG's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

4SC AG Additional Paid-In Capital Chart

4SC AG Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Additional Paid-In Capital

Get a 7-Day Free Trial

210.44

233.92

270.67

253.76

261.23

4SC AG Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Additional Paid-In Capital	Get a 7-Day Free Trial															270.67	253.22	253.76	259.53	261.23

4SC AG Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital

(Issue Price

Par Value)

Shares Outstanding (Diluted Average)

4SC AG Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of 4SC AG's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

4SC AG (4SC AG) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » 4SC AG (GREY:FSCGF) » Definitions » Additional Paid-In Capital

Comparable Companies

Traded in Other Exchanges

VSC:Germany

Address

Fraunhoferstraße 22, Planegg-Martinsried, DEU, 82152

Website

https://www.4sc.com

4SC AG is a clinical-stage biopharmaceutical company developing small-molecule drugs that can target key indications in cancer with high unmet medical needs. Its pipeline is protected by a comprehensive portfolio of patents and currently comprises two drug candidates in clinical development resminostat and Domatinostat. It Geographic area of the company is Germany, the EU, and Other countries, and the majority of the revenue comes from Other Countries.